Identification of a new form of death-associated protein kinase that promotes cell survival

Y Jin1, E K Blue, S Dixon

  • 1Department of Cellular and Integrated Physiology, Indiana University School of Medicine, 635 Barnhill Dr., Indianapolis, IN 46202, USA.

Insights

Two mouse death-associated protein kinase (DAPK) forms were studied. DAPK-beta, unlike DAPK-alpha, protects cells from TNF-induced apoptosis by inhibiting key signaling pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Two alternatively spliced forms of mouse death-associated protein kinase (DAPK) were identified.
  • DAPK shares structural similarities with myosin light chain kinases, indicating potential roles in cellular signaling.

Purpose of the Study:

  • To investigate the distinct roles of mouse DAPK-alpha and DAPK-beta in apoptosis.
  • To elucidate the molecular mechanisms underlying DAPK's function in programmed cell death.

Main Methods:

  • Sequence analysis of DAPK isoforms.
  • Overexpression studies in cell lines.
  • Biochemical assays to analyze apoptotic signaling pathways.
  • Western blotting to detect protein expression and activity.

Main Results:

  • Mouse DAPK-alpha showed minimal impact on TNF-induced apoptosis.
  • Mouse DAPK-beta exhibited a significant cytoprotective effect against TNF-induced apoptosis.
  • DAPK-beta inhibited cytochrome c release and caspase-3/caspase-9 activity, suggesting a role in regulating mitochondrial apoptotic pathways.

Conclusions:

  • Mouse DAPK-beta acts as a negative regulator of TNF-induced apoptosis.
  • The cytoprotective function of DAPK-beta is mediated through both intrinsic and extrinsic apoptotic pathways.
  • Differential roles of DAPK isoforms in apoptosis regulation were highlighted.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...